Definitive Guide to Global Transparency Regulations for the Life Sciences In 2015, Zephyr Health released its first ‘Definitive Guide to Global Life Sciences Transparency Regulations’, outlining the Share XDefinitive Guide to Global Transparency Regulations for the Life Scienceshttps://pharmaphorum.com/whitepapers/transparency-regulations-life-sciences/
Seizing the potential of commercial outsourcing in the pharmaceutical sectorThe power and potential of outsourcing has long been recognised as a core enabler of business growth. Yet Share XSeizing the potential of commercial outsourcing in the pharmaceutical sectorhttps://pharmaphorum.com/whitepapers/seizing-potential-commercial-outsourcing-pharmaceutical-sector/
Planning, Executing, and Monitoring: The Three Pillars of an Effective Marketing CampaignNo longer are physicians the sole concern for the life sciences’ sales and marketing function. Today, as a Share XPlanning, Executing, and Monitoring: The Three Pillars of an Effective Marketing Campaignhttps://pharmaphorum.com/transversal-categories/sales-and-marketing/planning-executing-monitoring-three-pillars-effective-marketing-campaign/
Transforming compliance with technology The need for increased transparency is placing additional compliance pressure on the Life Sciences industry, especially on Share XTransforming compliance with technologyhttps://pharmaphorum.com/whitepapers/insightfully-compliant-how-technology-is-transforming-relationships-between-medical-affairs-and-healthcare-providers/
Understanding what works: A case study measuring return on investment for digital versus physical marketing activities and the combination of bothIn today’s healthcare environment, where we see increasingly complex stakeholder needs and decreased direct access to HCPs and Share XUnderstanding what works: A case study measuring return on investment for digital versus physical marketing activities and the combination of bothhttps://pharmaphorum.com/whitepapers/understanding-what-works-a-case-study-measuring-return-on-investment-for-digital-versus-physical-marketing-activities-and-the-combination-of-both/
Optimising patient outcomes through physician educationPhysician education is undergoing a massive change as the volume of advances in therapies and practices increases and Share XOptimising patient outcomes through physician educationhttps://pharmaphorum.com/whitepapers/optimising-patient-outcomes-through-physician-education/
Is pharma brand marketing dead?This comprehensive supplement brings together a series of articles, insights and discussions produced by Kantar Health in order Share XIs pharma brand marketing dead?https://pharmaphorum.com/whitepapers/is-pharma-brand-marketing-dead/
How do doctors want to engage with pharma on new products?With more than 80 per cent of European doctors saying they want to stay abreast of new developments Share XHow do doctors want to engage with pharma on new products?https://pharmaphorum.com/whitepapers/how-do-doctors-want-to-engage-with-pharma-on-new-products/
“The future ain’t what it used to be”Preparation is key to creating and maintaining a strong drugs pipeline. However, the statistics demonstrate that successful product Share X“The future ain’t what it used to be”https://pharmaphorum.com/whitepapers/the-future-ain-t-what-it-used-to-be/
